- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 15 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 41 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 6 residues within 4Å:- Chain A: N.123, T.125, N.126, V.127, F.128, V.171
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: Y.31, S.63, N.64
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: N.353, R.354, R.465
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.164, N.165
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.342, F.370
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: T.109, N.233
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: N.330, P.577, Q.578, L.580
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain A: N.614, T.616
- Chain C: K.833, Y.835
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: Y.653, N.655
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: S.706, N.707
- Chain C: Y.794
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain A: A.704, A.711, E.1070, N.1072
- Chain C: Q.893
Ligand excluded by PLIPNAG.27: 6 residues within 4Å:- Chain B: N.123, A.124, T.125, N.126, F.128, V.171
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: Y.31, T.32, N.33, N.64
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.353, R.354
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.164, N.165
- Chain C: Y.350
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.342
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.330, Q.578, L.580
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: Y.653, N.655
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain A: Y.794
- Chain B: S.706, N.707
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain B: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.37: 6 residues within 4Å:- Chain B: N.233
- Chain C: R.456, L.460, K.461, E.464, D.466
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain C: N.123, T.125, V.127, V.171
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: Y.31, F.62, S.63, N.64
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: N.164, N.165
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.233
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain B: I.832, K.833, Y.835
- Chain C: N.614, T.616
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: Y.653, N.655
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: I.792, Y.794
- Chain C: N.707
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: A.704, E.1070, N.1072
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: H.338, N.342, F.370
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.353
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.330, V.331, T.332
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain D: D.525, S.527, N.528
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain D: K.8, N.72
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain D: N.304
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain D: N.35, T.37, N.40
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain E: A.515, N.528
Ligand excluded by PLIPNAG.58: 4 residues within 4Å:- Chain E: V.298, G.301, L.302, N.304
Ligand excluded by PLIPNAG.59: 5 residues within 4Å:- Chain E: N.31, T.34, N.35, N.40, M.314
Ligand excluded by PLIPNAG.60: 1 residues within 4Å:- Chain E: N.72
Ligand excluded by PLIP- 2 x ZN: ZINC ION(Non-covalent)
ZN.49: 5 residues within 4Å:- Chain D: H.356, H.360, H.383, E.384, G.387
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.356, D:H.360, D:E.384, D:E.384
ZN.55: 4 residues within 4Å:- Chain E: H.356, E.357, H.360, G.387
3 PLIP interactions:3 interactions with chain E- Metal complexes: E:H.356, E:H.356, E:H.360
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-07-03
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 15 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 41 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-07-03
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E